Abattis Announces Receipt of Cultivation License by LP Partner (PR)

0 Responses Abattis News | Experion

VANCOUVER, British Columbia / GLOBE NEWSWIRE / Aug. 21, 2017 Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (ATTBF) and its majority-owned testing and laboratory subsidiary, Northern Vine Canada Inc. (“Northern Vine”), are pleased to announce that their Licensed Producer (LP) investment partner, Experion Biotechnologies Inc. (“Experion”), has officially received an Access to Cannabis for […]

Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc. (PR)

0 Responses Abattis News | Experion

VANCOUVER, BC / ACCESSWIRE / October 24, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces that Abattis and Northern Vine have entered into a Binding Memorandum of Agreement with Experion Biotechnologies to acquire up to 100% of Experion Biotechnologies Inc. Abattis Bioceuticals Corp., and its subsidiary Northern Vine Canada Inc., expect to […]

Abattis Bioceuticals Corp: Experion Biotechnologies Prepares for Construction (PR)

0 Responses Abattis News | Experion | Northern Vine

VANCOUVER, BC / ACCESSWIRE / October 17, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces commencement of construction for the Experion secure, production facility. Experion Biotechnologies Inc. is pleased to announce that it has begun the construction process and prepares to break ground for the six-month build-out for its 8,000 square foot, […]